Infants under 1 year of age have a significant risk of burn injury

Dai Q A Nguyen1, Sean Tobin, William A Dickson

  • 1The Welsh Centre for Burns and Plastic Surgery, Morriston, Swansea, United Kingdom. dainguyen@doctors.org.uk

Insights

Infants under one year old experienced 104 burn admissions, primarily scalds from hot drinks and contact burns from household items. This highlights a critical need for targeted burn prevention strategies for this vulnerable age group.

Area of Science:

  • Pediatric burn epidemiology
  • Infant injury prevention
  • Public health

Background:

  • Limited data exists on burn epidemiology specifically in infants under one year old.
  • This age group is developing mobility, increasing potential for home accidents.
  • Understanding infant burn causes is crucial for effective prevention.

Purpose of the Study:

  • To analyze the epidemiology of burns in infants under one year of age.
  • To identify common burn types, sources, and demographic patterns.
  • To inform targeted burn prevention strategies for this population.

Main Methods:

  • Retrospective study of burn admissions in infants (<1 year) at The Welsh Centre for Burns (Jan 2003 - Jan 2006).
  • Analysis of 104 identified burn cases, representing 11.8% of pediatric admissions.
  • Categorization of burn types (scalds, contact), sources, and total body surface area (TBSA) affected.

Main Results:

  • Burns increased with age, predominantly occurring in the home environment.
  • Scalds were the most common burn type (65%), followed by contact burns (30%).
  • Common scald sources included hot drinks (39%); contact burns involved radiators/hot water pipes (30%). Mean TBSA was 2.3%.

Conclusions:

  • The high frequency of burns in infants underscores the need for focused prevention efforts.
  • Specific attention to scalds from hot drinks and bottle warming, and contact burns from household heating elements is required.
  • Developing tailored prevention advice for caregivers of infants is essential.

Related Concept Videos

Burn Injuries01:22

Burn Injuries

Burn injuries occur when the skin and underlying tissues are damaged due to exposure to heat, electricity, chemicals, radiation, or friction. They can vary in severity, from minor superficial burns to severe deep burns that can be life-threatening.
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...